CompareMarketResearchRequest a sample
Home / Healthcare / High-end Cellomics

Healthcare · Market report

High-end Cellomics Market Size, Share and Forecast 2026-2036

The global high-end cellomics market is worth USD 610 mn in 2026 and is forecast to reach USD 1.2 bn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Confocal high-content systems is the largest by system segment.

USD 610 mnMarket size 2026
USD 1.2 bnForecast 2036
7.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global high-end cellomics market is worth USD 610 mn in 2026 and is forecast to reach USD 1.2 bn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Confocal high-content systems is the largest by system segment.

ScopeHigh-content cell imaging and analysis systems (cellomics): automated microscopes with image analysis software used for drug screening and cell biology.
IndustryHealthcare
Value 2025USD 570 mn
Value 2026USD 610 mn
Value 2036USD 1.2 bn
CAGR 2026-20367.0%
Volume 20262,129 units
Volume 20363,985 units
Average price 2026USD 286,400 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

High-end Cellomics market size and forecast, 2026-2036

Exhibit 1The global high-end cellomics market is forecast to grow from USD 610 mn in 2026 to USD 1.2 bn by 2036, a rise of 97%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 7.0%
High-end Cellomics market value, 2025 to 2036Market value by year. 2025: USD 570 mn; 2026: USD 610 mn; 2027: USD 653 mn; 2028: USD 698 mn; 2029: USD 747 mn; 2030: USD 799 mn; 2031: USD 855 mn; 2032: USD 915 mn; 2033: USD 979 mn; 2034: USD 1.0 bn; 2035: USD 1.1 bn; 2036: USD 1.2 bn. Compound annual growth rate 2026 to 2036: 7.0%.2025610 mn2026855 mn20311.2 bn20367.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 610 mn
2027USD 653 mn
2028USD 698 mn
2029USD 747 mn
2030USD 799 mn
2031USD 855 mn
2032USD 915 mn
2033USD 979 mn
2034USD 1.0 bn
2035USD 1.1 bn
2036USD 1.2 bn

High-end Cellomics market segmentation

By system

Exhibit 2Confocal high-content systems is the largest segment by system, with 42.0% of 2026 revenueEstimated share of 2026 global revenue, by system
High-end Cellomics market share by system, 2026Share of 2026 revenue by system. Confocal high-content systems: 42.0%; Widefield high-content systems: 34.0%; Live-cell and 3D organoid imagers: 24.0%.Confocal high-content systems42.0%Widefield high-content systems34.0%Live-cell and 3D organoid imagers24.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Confocal high-content systems42.0%43.5%USD 256 mn7.4%
Widefield high-content systems34.0%27.9%USD 207 mn4.9%
Live-cell and 3D organoid imagers24.0%28.6%USD 146 mn8.9%

By end use

Exhibit 3Pharma and biotech drug discovery adds the most revenue by end use, growing from USD 342 mn in 2026 to USD 673 mn by 2036Estimated revenue in USD by end use, 2026 and 2036 forecast
High-end Cellomics market by end use, 2026 and 2036Revenue by end use in 2026 and 2036. Pharma and biotech drug discovery: USD 342 mn in 2026, USD 673 mn in 2036, change +97%; Academic research: USD 171 mn in 2026, USD 306 mn in 2036, change +79%; Contract research organisations: USD 98 mn in 2026, USD 221 mn in 2036, change +126%.20262036 forecastChangePharma and biotech drug discovery+97%342 mn673 mnAcademic research+79%171 mn306 mnContract research organisations+126%98 mn221 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Pharma and biotech drug discovery56.0%56.1%USD 342 mn7.0%
Academic research28.0%25.5%USD 171 mn6.0%
Contract research organisations16.0%18.4%USD 98 mn8.5%

By application

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Phenotypic drug screening34.0%32.0%USD 207 mn6.3%
Toxicology20.0%19.0%USD 122 mn6.5%
Target identification and validation22.0%22.0%USD 134 mn7.0%
Cell biology research24.0%27.0%USD 146 mn8.3%

By offering

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Imaging instruments50.0%42.0%USD 305 mn5.2%
Consumables28.0%30.0%USD 171 mn7.7%
Analysis software22.0%28.0%USD 134 mn9.6%

By throughput

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Medium38.0%34.0%USD 232 mn5.8%
High40.0%42.0%USD 244 mn7.5%
Ultra-high22.0%24.0%USD 134 mn7.9%

Top 25 countries for high-end cellomics by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 90.5% of 2026 revenue and the 25 countries below together hold 97.6%.

Exhibit 4United States is the largest country market at USD 232 mn in 2026, and the three largest countries hold 59.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
High-end Cellomics market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 232 mn, 38.0%; China: USD 79 mn, 13.0%; Germany: USD 49 mn, 8.0%; Japan: USD 43 mn, 7.0%; United Kingdom: USD 37 mn, 6.0%; France: USD 27 mn, 4.5%; Switzerland: USD 24 mn, 4.0%; South Korea: USD 24 mn, 4.0%; India: USD 18 mn, 3.0%; Canada: USD 18 mn, 3.0%.United States232 mn 38.0%China79 mn 13.0%Germany49 mn 8.0%Japan43 mn 7.0%United Kingdom37 mn 6.0%France27 mn 4.5%Switzerland24 mn 4.0%South Korea24 mn 4.0%India18 mn 3.0%Canada18 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 232 mn38.0%USD 425 mn6.2%
2ChinaUSD 79 mn13.0%USD 200 mn9.7%
3GermanyUSD 49 mn8.0%USD 90 mn6.3%
4JapanUSD 43 mn7.0%USD 74 mn5.7%
5United KingdomUSD 37 mn6.0%USD 67 mn6.3%
6FranceUSD 27 mn4.5%USD 50 mn6.3%
7SwitzerlandUSD 24 mn4.0%USD 47 mn6.7%
8South KoreaUSD 24 mn4.0%USD 54 mn8.3%
9IndiaUSD 18 mn3.0%USD 47 mn9.8%
10CanadaUSD 18 mn3.0%USD 34 mn6.3%
11NetherlandsUSD 4.9 mn0.8%USD 9.2 mn6.6%
12AustraliaUSD 4.3 mn0.7%USD 8.2 mn6.7%
13SingaporeUSD 3.7 mn0.6%USD 8.6 mn9.0%
14ItalyUSD 3.0 mn0.5%USD 5.8 mn6.6%
15SpainUSD 3.0 mn0.5%USD 5.8 mn6.6%
16BelgiumUSD 3.0 mn0.5%USD 5.8 mn6.6%
17DenmarkUSD 3.0 mn0.5%USD 5.8 mn6.6%
18SwedenUSD 3.0 mn0.5%USD 5.8 mn6.6%
19TaiwanUSD 3.0 mn0.5%USD 5.8 mn6.6%
20IsraelUSD 2.4 mn0.4%USD 4.7 mn6.7%
21IrelandUSD 2.4 mn0.4%USD 4.7 mn6.7%
22BrazilUSD 1.8 mn0.3%USD 4.3 mn9.0%
23AustriaUSD 1.8 mn0.3%USD 3.5 mn6.6%
24FinlandUSD 1.8 mn0.3%USD 3.5 mn6.6%
25NorwayUSD 1.8 mn0.3%USD 3.5 mn6.6%
Rest of worldUSD 15 mn2.4%USD 27 mn6.3%
Exhibit 5United States and China account for 53% of the USD 590 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
High-end Cellomics market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 610 mn. United States: +USD 193 mn; China: +USD 121 mn; Germany: +USD 41 mn; Japan: +USD 32 mn; United Kingdom: +USD 31 mn; 20 other countries: +USD 160 mn; Rest of world: +USD 12 mn. Market value 2036: USD 1.2 bn.Market value 2026610 mnUnited States+193 mnChina+121 mnGermany+41 mnJapan+32 mnUnited Kingdom+31 mn20 other countries+160 mnRest of world+12 mnMarket value 20361.2 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Thermo Fisher Scientific
  • Revvity
  • Molecular Devices
  • Agilent Technologies
  • Carl Zeiss
  • Leica Microsystems

Group 2: Regional and specialist players

  • Yokogawa Electric
  • Olympus
  • Nikon
  • Cytiva
  • Bruker
  • Logos Biosystems
  • Nanolive
  • Hamamatsu Photonics

Group 3: Emerging and niche players

  • Cytena
  • Sartorius
  • Etaluma
  • Curiosis
  • Oxford Nanoimaging
  • Axion BioSystems

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the high-end cellomics market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.0% is calculated from the resulting values.

The market is divided by system, by end use, by application, by offering, by throughput. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the high-end cellomics market?

The global high-end cellomics market is estimated at USD 570 mn in 2025 and USD 610 mn in 2026.

How fast will the high-end cellomics market grow?

It is forecast to reach USD 1.2 bn by 2036, a compound annual growth rate of 7.0% from 2026, an increase of USD 590 mn.

Which country is the largest market for high-end cellomics?

United States is the largest market by revenue at USD 232 mn in 2026, 38.0% of the global total. The three largest countries together hold 59.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 9.8% a year from 2026 to 2036.

Which high-end cellomics segment is largest?

In the by system split, Confocal high-content systems is the largest segment with 42.0% of 2026 revenue.

Who are the leading high-end cellomics companies?

Global leaders include Thermo Fisher Scientific, Revvity, Molecular Devices, Agilent Technologies.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Healthcare Reimbursement Optimization Home Healthcare →

All Healthcare markets →

Request a sample